Cuba Headlines

Cuba News, Breaking News, Articles and Daily Information

ciencia y tecnica 1.jpg
The therapeutic vaccine for advanced lung cancer of the Centre for Molecular Immunology and the development of three anti-allergy vaccines at the National Centre for Bio-derivates (BIOCEN) stand out among the relevant contributions of the Island’s science and technological innovation throughout 2009.

Achieved by multidisciplinary teams of Cuban specialists, the said formulations generate products of high-added value that not only improve the quality of life, but increase exportable items as well.

Add to this the application of Heberprot-P, a reality in the specialty of vascular surgery throughout the country.

Manufactured from Epidemic Growth Factor (EGF), this last is markedly effective in foot injuries due to diabetics, since it enables a quick cicatrisation and avoids amputations.

Produced at the Centre for Genetic Engineering and Biotechnology, its successful results are achieved through an injection formula, administered through infiltration, thus accelerating the skin granulation and cicatrisation in 54 percent of diabetic foot ulcers.

With a high demand, the drug has already benefited over 1500 people on the Island, and its application has also extended to the Bolivarian Republic of Venezuela in patients who report that type of ulcer caused by blood circulation problems and primary blows.

Official stats confirm that 15 percent of the world’s diabetic population develops a diabetic foot ulcer at some time of their life, and as a result of that every 30 seconds a person undergoes an amputation.

The diabetic population on the island constitutes 4.5 percent of the whole population, and it’s estimated that some 12000 patients get this type of illness a year, hence the importance of this drug, exclusive in the world, that is being applied in other nations now.

Described as a relevant scientific contribution, it is a hope for more than 170 million people in the world who suffer from Mellitus Diabetics today and this figure could duplicate in the coming years.

Along with Heberprot-P there are other achievements from Cuban science and technological innovation of the year that has just finished, and among them highlights to Surfacen, a drug destined to improve respiratory failure in adults, of the National Centre for Animal Health.

The year also features relevant contributions in the agricultural branch such as the climatic characterization of the Sagua-Nipe-Baracoa mountain range, the genetic improvement of tomato through molecular markers and the obtaining of new rice varieties.

Source: Cubasí

Related News